TYRA Valuation

Tyra Biosciences Inc

Add to Watchlist

Advanced Chart

11.060

+0.28(2.597%)1D

Overview
Forecast
Valuation
Earnings

TYRA Relative Valuation

TYRA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TYRA is overvalued; if below, it's undervalued.

Historical Valuation

Tyra Biosciences Inc (TYRA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -8.91. The fair price of Tyra Biosciences Inc (TYRA) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：10.78

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.77

P/B

Median3y

2.24

Median5y

2.09

-13.48

FCF Yield

Median3y

-9.53

Median5y

-8.66

Competitors Valuation Multiple

The average P/S ratio for TYRA's competitors is 32.25, providing a benchmark for relative valuation. Tyra Biosciences Inc Corp (TYRA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap